Advised C&O Pharmaceutical on its exit from a joint venture in China and the negotiation of shareholder buyout and valuation of share price of CRO.
-
合伙人
){kind=logo}
It looks like we may have content for your preferred language. Would you like to view this page in English?
Email has been submitted successfully. Thanks!
Error sending the email. Please try again later.
Error with download